Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
29,881,634
-
Total 13F shares
-
7,009,150
-
Share change
-
+2,396,569
-
Total reported value
-
$123,510,789
-
Put/Call ratio
-
78%
-
Price per share
-
$17.64
-
Number of holders
-
44
-
Value change
-
+$42,298,243
-
Number of buys
-
36
-
Number of sells
-
9
Institutional Holders of Profound Medical Corp. - Common Shares (PROF) as of Q3 2020
As of 30 Sep 2020,
Profound Medical Corp. - Common Shares (PROF) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,009,150 shares.
The largest 10 holders included
FIL Ltd, Redmile Group, LLC, PURA VIDA INVESTMENTS, LLC, GAGNON SECURITIES LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Park West Asset Management LLC, AWM Investment Company, Inc., Gagnon Advisors, LLC, RTW INVESTMENTS, LP, and Blackcrane Capital, LLC.
This page lists
44
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.